Atellica IM High-Sensitivity Troponin I Assay is First in the U.S. to Include Prognostic Risk
Siemens Healthineers High-Sensitivity Troponin I (TnIH) can be used to aid in offering rapid and accurate detection of AMI helping lead to a faster diagnosisA and now also assists clinicians to help identify future cardiovascular event risk based on the new FDA-cleared prognostic risk claim extension